An experimental drug from Revolution Medicines that nearly ​doubled survival time for patients with advanced pancreas cancer ...

For patients taking GLP-1 receptor agonists (GLP-1 RAs), the use of proton pump inhibitors (PPIs) is associated with an increased risk for gastrointestinal (GI) adverse effects, according to research ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

The procedure might be trendy, but it comes with risks and doesn't address the root causes of digestive problems.

Pancreatic cancer is one of the most dire diagnoses in medicine. There are few available treatments, and they do little to ...

Too much magnesium can cause diarrhea, nausea, and more serious symptoms. Learn the signs of excess magnesium and when to ...

A groundbreaking cancer drug has shown promise against deadly, hard-to-treat pancreatic tumours in a small clinical trial 1. The drug, daraxonrasib, inhibits a family of proteins known as RAS that can ...

Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are ...

Can the new GLP-1s help prevent cancer before it starts by tackling obesity and all the dysfunctional metabolic pathways that ...

A BMJ systematic review of 59 human studies found no evidence supporting causal links between aluminum-adjuvanted vaccines ...

It’s tough to avoid the current hype about the health benefits of injecting peptides. Although these substances – essentially ...

Glow stacks are the latest skin-care trend. But there are serious safety concerns to consider before trying one of these ...